MapLight Therapeutics Statistics
Total Valuation
MPLT has a market cap or net worth of $1.51 billion. The enterprise value is $1.20 billion.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MPLT has 45.35 million shares outstanding. The number of shares has increased by 2,509.30% in one year.
| Current Share Class | 42.62M |
| Shares Outstanding | 45.35M |
| Shares Change (YoY) | +2,509.30% |
| Shares Change (QoQ) | +40.83% |
| Owned by Insiders (%) | 3.73% |
| Owned by Institutions (%) | 38.07% |
| Float | 13.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.76 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.91, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.91 |
| Quick Ratio | 21.71 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -80.95% and return on invested capital (ROIC) is -52.01%.
| Return on Equity (ROE) | -80.95% |
| Return on Assets (ROA) | -49.51% |
| Return on Invested Capital (ROIC) | -52.01% |
| Return on Capital Employed (ROCE) | -51.93% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.50M |
| Employee Count | 133 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 29.28 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 62.20 |
| Average Volume (20 Days) | 466,993 |
Short Selling Information
The latest short interest is 1.90 million, so 4.19% of the outstanding shares have been sold short.
| Short Interest | 1.90M |
| Short Previous Month | 1.56M |
| Short % of Shares Out | 4.19% |
| Short % of Float | 14.17% |
| Short Ratio (days to cover) | 6.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -210.04M |
| Pretax Income | -199.48M |
| Net Income | -199.48M |
| EBITDA | -209.47M |
| EBIT | -210.04M |
| Earnings Per Share (EPS) | -$10.07 |
Full Income StatementBalance Sheet
The company has $310.11 million in cash and $5.59 million in debt, giving a net cash position of $304.52 million or $6.72 per share.
| Cash & Cash Equivalents | 310.11M |
| Total Debt | 5.59M |
| Net Cash | 304.52M |
| Net Cash Per Share | $6.72 |
| Equity (Book Value) | 399.83M |
| Book Value Per Share | 8.84 |
| Working Capital | 312.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$163.77 million and capital expenditures -$497,000, giving a free cash flow of -$164.26 million.
| Operating Cash Flow | -163.77M |
| Capital Expenditures | -497,000 |
| Depreciation & Amortization | 574,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -164.26M |
| FCF Per Share | -$3.62 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |